Transplantation, Kidney Clinical Trial
Official title:
The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group
The study hypothesis is that erythropoietin usage after kidney transplantation, in early phase, can improve the outcome for patients and their graft increasing patient and graft survival.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00189735 -
A Study to Evaluate FK778 in Kidney Transplant Patients
|
Phase 2 | |
| Recruiting |
NCT01150487 -
Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients
|
N/A | |
| Completed |
NCT01656343 -
Belatacept and Risk of Post-transplant Lymphoproliferative Disorder in US Renal Transplant Recipients
|
||
| Completed |
NCT02625428 -
IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?
|
Phase 4 | |
| Terminated |
NCT00365833 -
CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients
|
N/A | |
| Withdrawn |
NCT01496729 -
Transversus Abdominis Plane (TAP) Block After Kidney Transplantation
|
N/A | |
| Completed |
NCT00861536 -
Comparison of ATG to Thymoglobuline in Renal Transplantation
|
Phase 4 | |
| Completed |
NCT00614081 -
GFR Measurement With Contrast-enhanced Dynamic MRI
|
N/A | |
| Completed |
NCT03977051 -
Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients
|
||
| Terminated |
NCT00568477 -
Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
|
Phase 2 | |
| Completed |
NCT04874740 -
Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region
|
||
| Available |
NCT01236287 -
Special Access for the Use of Voclosporin for Kidney Transplantation
|